Rgenix is a privately-held clinical-stage biopharmaceutical company developing first-in-class drugs that target key pathways in cancer progression.

310 E 67th St, Suite 1-12‎, New York, NY 10065
(646) 856-9261
[email protected]

Samantha Karpinski

Clinical Trial Associate

Samantha Karpinski is a Clinical Trial Associate as Inspirna. She received a B.S. in biology from Montclair State University. She has 10 years of experience in the clinical operations industry with a focus on late phase studies. Prior to Inspirna, Samantha worked with Octapharma USA, Inc within the US clinical ops team supporting immunology and emergent care research studies.